BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16786240)

  • 1. New tools for G-protein coupled receptor (GPCR) drug discovery: combination of baculoviral expression system and solid state NMR.
    Ratnala VR
    Biotechnol Lett; 2006 Jun; 28(11):767-78. PubMed ID: 16786240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological relevance of GPCR oligomerization and its impact on drug discovery.
    Panetta R; Greenwood MT
    Drug Discov Today; 2008 Dec; 13(23-24):1059-66. PubMed ID: 18824244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I want a new drug: G-protein-coupled receptors in drug development.
    Schlyer S; Horuk R
    Drug Discov Today; 2006 Jun; 11(11-12):481-93. PubMed ID: 16713899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based assays in GPCR drug discovery.
    Siehler S
    Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.
    Colette J; Avé E; Grenier-Boley B; Coquel AS; Lesellier K; Puget K
    J Pept Sci; 2007 Sep; 13(9):568-74. PubMed ID: 17694568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand identification for G-protein-coupled receptors: a lead generation perspective.
    Bleicher KH; Green LG; Martin RE; Rogers-Evans M
    Curr Opin Chem Biol; 2004 Jun; 8(3):287-96. PubMed ID: 15183327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting neurotrophic effects by GPCR ligands.
    Jeanneteau F; Chao MV
    Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptorome screening for CNS drug discovery.
    Vortherms TA; Roth BL
    IDrugs; 2005 Jun; 8(6):491-6. PubMed ID: 15906196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts in drug discovery: collateral efficacy and permissive antagonism.
    Kenakin T
    Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPCR-GIP networks: a first step in the discovery of new therapeutic drugs?
    Bockaert J; Dumuis A; Fagni L; Marin P
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):649-57. PubMed ID: 15503867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.